Related references
Note: Only part of the references are listed.Comparison of Serum Tumor Associated Material (TAM) with Conventional Biomarkers in Cancer Patients
Jian Shu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer
Chun-Wen Cheng et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells
Y. Yu et al.
LEUKEMIA (2012)
MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer
F. German Rodriguez-Gonzalez et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis
Xiaogang Tan et al.
CLINICAL CANCER RESEARCH (2011)
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in Patients With Hepatocellular Carcinoma or Chronic Hepatitis
Jian Xu et al.
MOLECULAR CARCINOGENESIS (2011)
Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer
Fulya Yaman Agaoglu et al.
TUMOR BIOLOGY (2011)
Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma
Joana Heinzelmann et al.
WORLD JOURNAL OF UROLOGY (2011)
Prospective Evaluation of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 15.3 (CA 15.3) in Patients with Primary Locoregional Breast Cancer
Rafael Molina et al.
CLINICAL CHEMISTRY (2010)
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
Zhaohui Huang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms
Jeanne S. Mandelblatt et al.
ANNALS OF INTERNAL MEDICINE (2009)
Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement
Ned Calonge et al.
ANNALS OF INTERNAL MEDICINE (2009)
The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform
Kimberly E. Resnick et al.
GYNECOLOGIC ONCOLOGY (2009)
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
Charles H. Lawrie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Subtypes of breast cancer show preferential site of relapse
Marcel Smid et al.
CANCER RESEARCH (2008)
Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer
Masahiro Uehara et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
Mammography facility characteristics associated with interpretive accuracy of screening mammography
Stephen Taplin et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
A microRNA-based gene dysregulation pathway in Huntington's disease
Rory Johnson et al.
NEUROBIOLOGY OF DISEASE (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
I. A. Asangani et al.
ONCOGENE (2008)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
Real-time expression profiling of microRNA precursors in human cancer cell lines
JM Jiang et al.
NUCLEIC ACIDS RESEARCH (2005)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
